IP Verse

Liquid Pharmaceutical Composition - EP3145488

The patent EP3145488 was granted to Ares Trading on Jul 22, 2020. The application was originally filed on May 15, 2015 under application number EP15723695A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3145488

ARES TRADING
Application Number
EP15723695A
Filing Date
May 15, 2015
Status
Opposition Rejected
Jul 26, 2024
Publication Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SAMSUNG BIOEPISApr 22, 2021PATENT BOUTIQUEADMISSIBLE
BIOGENJul 22, 2020PATENT BOUTIQUEADMISSIBLE
SAMSUNG BIOEPISJul 22, 2020PATENT BOUTIQUEWITHDRAWN

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO9729131
INTERNATIONAL-SEARCH-REPORTUS2004033228
INTERNATIONAL-SEARCH-REPORTUS2010137213
INTERNATIONAL-SEARCH-REPORTUS2010278822
INTERNATIONAL-SEARCH-REPORTWO2009073569
INTERNATIONAL-SEARCH-REPORTWO2011104381
INTERNATIONAL-SEARCH-REPORTWO2013164837
OPPOSITIONIN1606MUM2012
OPPOSITIONWO2014039903
OPPOSITIONWO2015177057
OPPOSITIONWO2015177058

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- ZHENG J Y ET AL, "Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, NL, vol. 308, no. 1-2, ISSN 0378-5173, (20060203), pages 46 - 51, (20060203), XP027972782
OPPOSITION- "Alternative buffers for pharmaceutical anti-TNFalpha monoclonal antibody formulations [Elektronische Ressource]", PAPDEOTT002384, (20130206), page 10 pp, XP009188701
OPPOSITION- Anonymous, "Pharmaceutical Formulation Development of Peptides and Proteins", Peptides and Proteins as Parenteral Solutions, CRC Press, (20060101), page 155, XP055961250
OPPOSITION- "National Formulary", United States Pharmacopeia, (20140501), vol. 37, no. 32, page 765, 766, 5828, XP055961246
OPPOSITION- V. K. Sharma, Et Al., "Chapter 30: The Formulation and Delivery of Monoclonal Antibodies", Therapeutic Monoclonal Antibodies: From Bench to Clinic, (20090101), pages 675 - 709, XP055593299
OPPOSITION- Sampathkumar Krishnan, Monica M. Pallitto, Margaret S. Ricci, "Development of Formulations for Therapeutic Monoclonal Antibodies and Fc Fusion Proteins", Formulation and process development strategies for manufacturing biopharmaceuticals., New York , Wiley , (20100726), pages 383 - 427, doi:10.1002/9780470595886.ch16, ISBN 9780470118122, XP055188652
OPPOSITION- Nicholas W. Warne, "Formulation Development of Phase 1-2 Biopharmaceuticals: An Efficient and Timely Approach : Jameel/Manufacturing Biopharmaceuticals", Nicholas W. Warne, Jameel Feroz ; Hershenson Susan, Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals, Hoboken, N.J. , John Wiley & Sons, Inc. , (20100726), pages 147 - 159, doi:10.1002/9780470595886.ch6, ISBN 978-0-470-11812-2, XP055752685

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents